ATR 1072

HONG KONG, July 14, 2026 Akeso, Inc. has announced the launch of a Phase II clinical trial in the...

CHENGDU, China, July 14, 2026 HitGen Inc. has announced that its partner BioAge Labs has dosed the first participant...

SAN DIEGO, Calif., July 14, 2026 Atrium Therapeutics has achieved an important regulatory milestone after the U.S. Food and...